Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beauty Farm Medical & Health Industry's revenue for the
six
months ended in Dec. 2025 was €186.9 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €363.1 Mil.
Beauty Farm Medical & Health Industry's Revenue per Share for the
six
months ended in Dec. 2025 was €0.80.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €1.57.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Beauty Farm Medical & Health Industry Revenue Related Terms
Beauty Farm Medical & Health Industry Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beauty Farm Medical & Health Industry Revenue Chart
For the Medical Care Facilities subindustry, Beauty Farm Medical & Health Industry's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beauty Farm Medical & Health Industry Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Beauty Farm Medical & Health Industry's Revenue distribution charts can be found below:
* The bar in red indicates where Beauty Farm Medical & Health Industry's Revenue falls into.
Beauty Farm Medical & Health Industry Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €363.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beauty Farm Medical & Health Industry (FRA:XC5) has a Revenue of €363.1 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Beauty Farm Medical & Health Industry and its competitors.
Is Beauty Farm Medical & Health Industry's Revenue too high?
Beauty Farm Medical & Health Industry's current Revenue is €363.1 Mil. Overall, Beauty Farm Medical & Health Industry has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Beauty Farm Medical & Health Industry's Revenue compare to HCA and THC?
Beauty Farm Medical & Health Industry's Revenue of €363.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Beauty Farm Medical & Health Industry and its competitors. Beauty Farm Medical & Health Industry's current Revenue is €363.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beauty Farm Medical & Health Industry stock overvalued right now?
Beauty Farm Medical & Health Industry (FRA:XC5) has a current Revenue of €363.1 Mil. The stock's GF Value™ is €2.98, compared to a current price of €1.99 — trading 33.2% below its estimated fair value. The current Revenue is €363.1 Mil. Beauty Farm Medical & Health Industry's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Beauty Farm Medical & Health Industry (FRA:XC5), the current Revenue is €363.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beauty Farm Medical & Health Industry (FRA:XC5) Overvalued in 2026?
Based on GuruFocus' analysis, Beauty Farm Medical & Health Industry stock appears to be undervalued.
The current stock price of €1.99 is trading 33.2% below its estimated GF Value™ of €2.98.
Key valuation signals for FRA:XC5:
Revenue: €363.1 Mil
GF Value™: €2.98 vs. price of €1.99 (33.2% below fair value)
No single metric tells the full story. See the FRA:XC5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beauty Farm Medical & Health Industry Inc. provides beauty and wellness services in the People's Republic of China. It offers high-quality beauty and wellness services, aesthetic medical services, and subhealth medical services according to customers' individual needs. The company offers its products and services through brands such as Beauty Farm, Palaispa, Naturade, Cellcare, and Neology.
87GF Score
Get the complete analysis for FRA:XC5
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:XC5 has been successfully added to your 
